INMD

Inmode Ltd. Health Care Electromedical & Electrotherapeutic Apparatus Russell 3000
$13.22Close $837.6MMarket cap $12.76 – $16.6252-week range Nov 11, 2026Next report · before the open

Highlights

Cautions

  • Not in an uptrend 3 of 8 trend conditions
  • Lagging the market RS 23 · weaker than 77% of stocks over 12 months
  • Results soon Nov 11, 2026, in 10 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Feb 10, 2026
Off 12-month high 20%
1wk down 5.4% price change
1mo down 6.7% price change
12-month return down 10% market up 11% · its own down 22%
F-score 5 / 9 Mixed
Altman Z 9.64 Low risk
P/E 8.9× price / earnings
PEG — P/E / EPS growth
P/B 1.2× price / book
Earnings yield up 16.0% EBIT / enterprise value
Cheaper than 91% of the market · markedly cheap
Revenue growth down 6% year on year
EPS growth — latest quarter
Sales growth — latest quarter
ROE up 14% return on equity
Free cash margin up 23% $84.3M FCF
D/E — long-term debt / equity
Net debt / EBITDA -3.5× net cash
Interest cover —EBIT / interest
Piotroski tests
  • profitability slipped from last year
  • profits not fully backed by cash
  • short-term liquidity weakened
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • reduced long-term debt
  • no new shares issued
  • assets working harder

Trade setup

ATR% 1.6% $0.21 a day · 2×ATR $12.79
RS 23 / 99 vs the universe
Trend 3 / 8 trend template
Relative volume 0.9× vs 50-day average
Up/down volume 0.75 50 sessions
Implied move — no option chain · report Nov 11, 2026
Trend template · 3 of 8
  • Price above the 150 and 200-day averages: fails
  • 150-day average above the 200-day: passes
  • 200-day average rising for a month: fails
  • 50-day average above the 150 and 200-day: passes
  • Price above the 50-day average: fails
  • At least 30% above the 52-week low: fails
  • Within 25% of the 52-week high: passes
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Gross margin narrowing Gross margin fell from 80.3% to 78.5%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 6.2% over the year, from $394.8M to $370.5M.

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $370.5M -6% on FY2024
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $206.1M FY2021 · $357.6M FY2022 · $454.3M FY2023 · $492.0M FY2024 · $394.8M FY2025 · $370.5M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $93.8M -48% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $75.0M FY2021 · $165.0M FY2022 · $161.5M FY2023 · $197.9M FY2024 · $181.3M FY2025 · $93.8M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $84.3M -36% on FY2024
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $78.8M FY2021 · $173.9M FY2022 · $180.0M FY2023 · $176.1M FY2024 · $132.0M FY2025 · $84.3M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 79%
  • Net 25%
  • Free cash 23%
0% 100% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 85% · Net 36% · Free cash 38% FY2021 · Gross 85% · Net 46% · Free cash 49% FY2022 · Gross 84% · Net 36% · Free cash 40% FY2023 · Gross 84% · Net 40% · Free cash 36% FY2024 · Gross 80% · Net 46% · Free cash 33% FY2025 · Gross 79% · Net 25% · Free cash 23%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology
  • Cash
  • Long-term debt
$0 $500M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $68.9M FY2021 · Cash $68.1M FY2022 · Cash $97.5M FY2023 · Cash $144.4M FY2024 · Cash $155.3M FY2025 · Cash $302.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 63.36m -16.2% since FY2020
83.98m 63.36m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 75.57m FY2021 · 82.98m FY2022 · 82.54m FY2023 · 83.98m FY2024 · 69.56m FY2025 · 63.36m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $206.1M $357.6M $454.3M $492.0M $394.8M $370.5M
Gross margin 85% 85% 84% 84% 80% 79%
Operating income $72.8M $167.5M $197.9M $195.7M $112.5M $85.4M
Net income $75.0M $165.0M $161.5M $197.9M $181.3M $93.8M
Net margin 36% 46% 36% 40% 46% 25%
Earnings per share $0.89 $1.92 $1.89 $2.30 $2.25 $1.43
Free cash flow $78.8M $173.9M $180.0M $176.1M $132.0M $84.3M
Free cash margin 38% 49% 40% 36% 33% 23%
Cash $68.9M $68.1M $97.5M $144.4M $155.3M $302.5M
Shareholders' equity $254.0M $415.8M $554.6M $787.4M $703.8M $683.2M
Shares outstanding 75.57m 82.98m 82.54m 83.98m 69.56m 63.36m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Feb 10, 2026 Annual ↗ Dec 31, 2025 41d
Feb 4, 2025 Annual ↗ Dec 31, 2024 35d
Feb 13, 2024 Annual ↗ Dec 31, 2023 44d
Feb 14, 2023 Annual ↗ Dec 31, 2022 45d
Feb 10, 2022 Annual ↗ Dec 31, 2021 41d
Feb 10, 2021 Annual ↗ Dec 31, 2020 41d
Feb 18, 2020 Annual ↗ Dec 31, 2019 49d

Current reports